Welltower (NYSE:WELL) Stock Price Expected to Rise, Raymond James Analyst Says

Welltower (NYSE:WELL) had its price objective increased by equities researchers at Raymond James from $145.00 to $155.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “strong-buy” rating on the real estate investment trust’s stock. Raymond James’ target price points to a potential upside of 19.90% from the company’s previous close.

A number of other research analysts have also recently issued reports on the stock. StockNews.com upgraded shares of Welltower from a “sell” rating to a “hold” rating in a report on Wednesday, October 30th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Welltower from $115.00 to $137.00 and gave the company a “buy” rating in a report on Wednesday, August 21st. Mizuho lifted their price objective on shares of Welltower from $136.00 to $141.00 and gave the company an “outperform” rating in a report on Thursday, December 5th. Evercore ISI boosted their price target on shares of Welltower from $106.00 to $114.00 and gave the stock an “in-line” rating in a report on Monday, September 16th. Finally, Wells Fargo & Company restated an “equal weight” rating and set a $135.00 price target (up from $134.00) on shares of Welltower in a report on Tuesday, October 1st. Five analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Welltower currently has an average rating of “Moderate Buy” and a consensus price target of $123.63.

Welltower Stock Performance

Shares of WELL stock opened at $129.27 on Monday. The business’s 50 day simple moving average is $132.95 and its 200 day simple moving average is $120.59. Welltower has a one year low of $85.40 and a one year high of $140.75. The stock has a market capitalization of $80.50 billion, a PE ratio of 85.05, a PEG ratio of 2.88 and a beta of 1.20. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10.

Welltower (NYSE:WELL) last issued its quarterly earnings results on Monday, October 28th. The real estate investment trust reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.04 by ($0.31). Welltower had a net margin of 12.22% and a return on equity of 3.20%. The business had revenue of $2.06 billion during the quarter, compared to analyst estimates of $1.95 billion. During the same period last year, the firm posted $0.92 earnings per share. Welltower’s quarterly revenue was up 23.7% compared to the same quarter last year. As a group, research analysts forecast that Welltower will post 4.3 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in WELL. First Foundation Advisors bought a new stake in shares of Welltower in the second quarter valued at approximately $26,000. Meeder Asset Management Inc. bought a new stake in shares of Welltower in the second quarter valued at approximately $30,000. Centerpoint Advisors LLC bought a new stake in shares of Welltower in the second quarter valued at approximately $31,000. Fortitude Family Office LLC raised its position in shares of Welltower by 37.0% in the third quarter. Fortitude Family Office LLC now owns 289 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 78 shares during the period. Finally, Ashton Thomas Securities LLC bought a new stake in shares of Welltower in the third quarter valued at approximately $50,000. 94.80% of the stock is currently owned by hedge funds and other institutional investors.

Welltower Company Profile

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.